1. Academic Validation
  2. Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase

Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase

  • Nat Chem Biol. 2016 Oct;12(10):838-44. doi: 10.1038/nchembio.2151.
Lavoisier Ramos-Espiritu 1 2 Silke Kleinboelting 3 Felipe A Navarrete 4 Antonio Alvau 4 Pablo E Visconti 4 Federica Valsecchi 5 Anatoly Starkov 5 Giovanni Manfredi 5 Hannes Buck 1 Carolina Adura 2 Jonathan H Zippin 6 Joop van den Heuvel 7 J Fraser Glickman 2 Clemens Steegborn 3 Lonny R Levin 1 Jochen Buck 1
Affiliations

Affiliations

  • 1 Department of Pharmacology, Weill Cornell Medical College, New York, New York, USA.
  • 2 The High-Throughput Screening and Spectroscopy Resource Center, The Rockefeller University, New York, New York, USA.
  • 3 Department of Biochemistry, University of Bayreuth, Bayreuth, Germany.
  • 4 Department of Veterinary and Animal Science, University of Massachusetts, Amherst, Massachusetts, USA.
  • 5 Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York, USA.
  • 6 Department of Dermatology, Weill Cornell Medical College, New York, New York, USA.
  • 7 Helmholtz Zentrum fur Infektionsforschung, Braunschweig, Germany.
Abstract

The prototypical second messenger cAMP regulates a wide variety of physiological processes. It can simultaneously mediate diverse functions by acting locally in independently regulated microdomains. In mammalian cells, two types of adenylyl cyclase generate cAMP: G-protein-regulated transmembrane adenylyl cyclases and bicarbonate-, calcium- and ATP-regulated soluble adenylyl cyclase (sAC). Because each type of cyclase regulates distinct microdomains, methods to distinguish between them are needed to understand cAMP signaling. We developed a mass-spectrometry-based adenylyl cyclase assay, which we used to identify a new sAC-specific inhibitor, LRE1. LRE1 bound to the bicarbonate activator binding site and inhibited sAC via a unique allosteric mechanism. LRE1 prevented sAC-dependent processes in cellular and physiological systems, and it will facilitate exploration of the therapeutic potential of sAC inhibition.

Figures
Products